Is a 82 gene panel that includes assessment of non-coding variants.
In addition, it also includes the maternally inherited mitochondrial genome. Is ideal for patients with a clinical suspicion of Parkinson disease.Parkinson disease is the second most common neurodegenerative disorder, after Alzheimer disease. Its diagnosis is based on the clinical findings of tremor, rigidity, and bradykinesia. Psychiatric manifestations, which include depression and visual hallucinations, are common but not uniformly present. Dementia eventually occurs in at least 20% of cases. Mendelian (monogenic) forms of Parkinson disease are found in fewer than 5% of all patients and are inherited in an autosomal dominant, autosomal recessive, or, very rarely, X-linked manner. Mendelian forms of Parkinson disease have an earlier age of disease onset than families with typical, late-onset Parkinson disease. Non-Mendelian Parkinson disease is thought to result from the effects of multiple genes as well as environmental risk factors
Is a 82 gene panel that includes assessment of non-coding variants.
In addition, it also includes the maternally inherited mitochondrial genome. Is ideal for patients with a clinical suspicion of Parkinson disease.Parkinson disease is the second most common neurodegenerative disorder, after Alzheimer disease. Its diagnosis is based on the clinical findings of tremor, rigidity, and bradykinesia. Psychiatric manifestations, which include depression and visual hallucinations, are common but not uniformly present. Dementia eventually occurs in at least 20% of cases. Mendelian (monogenic) forms of Parkinson disease are found in fewer than 5% of all patients and are inherited in an autosomal dominant, autosomal recessive, or, very rarely, X-linked manner. Mendelian forms of Parkinson disease have an earlier age of disease onset than families with typical, late-onset Parkinson disease. Non-Mendelian Parkinson disease is thought to result from the effects of multiple genes as well as environmental risk factors
Test Duration: N/A
Home Sample Collection: No
Category: Cognition & Neurology Testing
Lab: N/A
Price: $0.00
Test Features
Genetic factors can contribute to a wide range of neurological and neurodevelopmental conditions. Our Neurological Genetics Panel helps identify inherited genetic variants associated with dementia, movement disorders, neurodevelopmental conditions, and other neurological diseases, providing valuable information for diagnosis, risk assessment, family planning, and clinical management.
Our comprehensive testing panels may include genetic causes associated with: ●Alzheimer's Disease and other forms of dementia ●Frontotemporal Dementia (FTD) ●Parkinson's Disease ●Huntington's Disease ●Amyotrophic Lateral Sclerosis (ALS) ●Hereditary Ataxias ●Epilepsy and seizure disorders ●Autism Spectrum Disorder (ASD) ●Intellectual and developmental disabilities ●Other inherited neurological conditions
●Individuals with symptoms suggestive of a neurological disorder ●Those with a family history of dementia, Parkinson's disease, or other neurological conditions ●Families seeking to understand inherited risks ●Individuals considering predictive or presymptomatic testing Parents investigating potential genetic causes of neurodevelopmental conditions
●Supports accurate diagnosis and clinical management ●Identifies inherited risk factors ●Assists with family planning decisions ●Helps inform treatment and surveillance strategies ●Provides clarity for patients and their families
Using a blood or saliva sample, advanced genetic sequencing technology analyses genes associated with neurological and neurodevelopmental conditions. Results are interpreted by experienced specialists and may be accompanied by genetic counselling to help you understand the findings and available options. Understanding your genetics can provide valuable answers, guide healthcare decisions, and help families plan for the future with greater confidence.
